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Introduction
Breast cancer–related lymphedema (BCRL) is the chronic 
swelling of the hand, arm, shoulder, and/or breast that 
occurs after treatment for breast cancer and is estimated to 
affect at least 20% of breast cancer survivors.1,2 Although 
the complex pathophysiology of BCRL remains unex-
plained, axillary lymph node removal and radiotherapy are 
considered the primary initiating factors.1,3 Damage to the 
lymphatic system in turn results in edema, chronic inflam-
mation, and accumulation of tissue protein in the affected 
limb.1,3 BCRL has a significant impact on quality of life.4,5 
Significant physical function impairment has been reported 
in both gross and fine motor tasks,1,6 as well as increased 
feelings of discomfort, pain, heaviness, and aching.7 
Additionally, women with BCRL exhibit significantly 
increased psychosocial morbidity, including depression, 
anxiety, and distress as well as displaying maladjustment to 
illness.8,9 These factors permeate all aspects of life, affecting 
work, home, and recreational activities as well as social 
relationships.4,10
Traditionally, clinical guidelines recommend that women 
with BCRL avoid vigorous, repetitive, or excessive upper 
body exercise to prevent exacerbation of lymphedema.11 
The conservative advice, aimed at minimizing risk of injury 
or harm to the involved side, indirectly encourages women 
to protect their limb, which in turn may lead them to limit 
their physical activity and in particular, the use of the affected 
side. However, such limitation of activity is theorized to hin-
der rehabilitation and in the longer term result in muscle 
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Abstract
Resistance exercise has great potential to aid in the management of breast cancer–related lymphedema (BCRL), but little 
is known regarding the acute response of performing resistance exercises with the affected limb. Purpose. To examine the 
acute impact of upper body resistance exercise on the amount of swelling and severity of symptoms in women with BCRL 
and to compare these effects between resistance exercise involving high and low loads (heavier vs lighter weights). Methods. 
Seventeen women aged 61 ± 9 years with mild to severe BCRL participated in this study. Participants completed a high 
load (6-8 repetition maximum) and low load (15-20 repetition maximum) exercise session consisting of 2 sets of 5 upper 
body resistance exercises in a randomized order separated by a 10- to 12-day wash-out period. The extent of swelling was 
assessed using bioimpedance spectroscopy, dual-energy x-ray absorptiometry, and arm circumference measurements. The 
severity symptoms were assessed using the visual analogue scale (pain, heaviness, and tightness) and a modified Brief Pain 
Inventory. Measurements were taken pre-exercise, immediately post-exercise, 24 hours post-exercise, and 72 hours post-
exercise. Results. No changes in the extent of swelling or the severity of symptoms were observed between pre-exercise 
and immediately post-exercise, 24 hours post-exercise, or 72 hours post-exercise. No differences in the response to the 
high or low load exercise were observed. Conclusions. Upper body resistance exercise does not acutely increase swelling 
or feelings of discomfort/pain, heaviness tightness in the affected limb of BCRL patients when performed at either high or 
low loads.
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atrophy, increased adiposity, and declining function.12 There 
is the potential that such conservative advice is actually 
counterproductive as a significant factor associated with the 
decline in functional activity and quality of life in those with 
BCRL appears to be a considerable loss of muscle strength 
in the affected limb.13,14 Women with BCRL have signifi-
cantly lower perceived and clinically measured upper body 
function and are more likely to report symptoms, such as 
pain, numbness, and stiffness, when compared with those 
without BCRL.13,14
The overwhelming consensus throughout the literature 
indicates that exercise is very beneficial for cancer patients, 
resulting in clinically meaningful improvements in quality of 
life, physical function, and structure as well as mental 
health.15-17 A growing body of literature provides evidence 
that these findings extend to patients with BCRL. A consis-
tent finding of this research is that exercise, including exer-
cise specifically involving the affected limb, does not appear 
to initiate or exacerbate BCRL.1,11,18-24 The risk of developing 
BCRL has been observed to be lower for patients who engage 
in regular physical activity compared with those who are sed-
entary (odds ratio = 1.9; 95% confidence interval = 0.5-2.9).1 
Furthermore, the incidence of BCRL was observed to be 
lower in a group of breast cancer survivors involved in regu-
lar resistance exercise compared with a usual care control 
group (11% vs 17%, respectively).20 The largest randomized 
controlled trial involving BCRL patients to date reported no 
difference over 12 months in interlimb volume difference 
between women involved in resistance exercise and usual 
care.21 Furthermore, the resistance exercise intervention had 
beneficial effects on the incidence of exacerbations, severity 
of lymphedema symptoms, and muscle strength.21
Upper body resistance exercise is emerging as a particu-
larly important therapy for survivors with BCRL as it is 
likely to support improved clearance of lymph through the 
effect of the muscle pump on venous and lymphatic clear-
ance.25-27 Increases in lean muscle mass, muscle strength, 
and endurance are also expected—changes that have sig-
nificant positive effects on physical functional ability.28-31 
Furthermore, these changes result in an elevated maximal 
work capacity, meaning that everyday tasks would require 
less effort. Importantly, the increased work capacity is theo-
rized to translate into reduced risk for lymphedema inci-
dence and exacerbation from everyday use of the affected 
arm.12 The clinical trials conducted to date provide strong 
evidence that maintaining or increasing strength of the 
upper body through resistance exercise aids in the manage-
ment of BCRL.11,12,18-22 Despite this, a paucity of research 
has examined the acute response of performing resistance 
exercises with the affected limb of women with BCRL and, 
most importantly, if exercise response would differ between 
common prescribed resistance training loads (ie, heavier vs 
lighter weights). In this study, we examined for the first 
time the acute (immediately after exercise bout) impact of 
upper body resistance exercise on the amount of swelling 
and severity of symptoms in women with BCRL and com-
pared these effects between resistance exercise involving 
high and low loads (ie, heavier vs lighter weights).
Methods
Participants
Sixty women with BCRL who were referred by oncologists 
and physiotherapists or who responded to advertisements 
via a local newspaper in the city of Perth, Western Australia 
from June through August 2010, were initially screened for 
participation in the study (Figure 1). Forty-three women 
were excluded from participation due to declining involve-
ment in the trial (n = 24); not meeting the criteria for clini-
cal diagnosis of lymphedema (n = 7); physician decline 
(n = 1); and other reasons (n = 11), such as travel con-
straints. Seventeen women were enrolled to participate in 
this study. Participants had a histological diagnosis of 
breast cancer at least 1 year prior to the study, a clinical 
diagnosis of BCRL, and obtained medical clearance from 
their physician. Clinical diagnosis of lymphedema was 
defined as having (a) an impedance ratio of at least 3 stan-
dard deviations greater than normative data,32,33 (b) a vol-
ume difference between affected and unaffected limbs of 
5% or more,33,34 and (c) a difference in circumference 
between affected and unaffected limbs of 5% or more.21,33,34 
Participants were excluded if they had (a) unstable lymph-
edema, defined as receiving intensive therapy (ie, decon-
gestive therapy or antibiotics for infection) within the 
previous 3 months, or (b) musculoskeletal, cardiovascular, 
and/or neurological disorders that could inhibit them from 
exercising. This protocol was approved by the university’s 
human research ethics committee, and all participants pro-
vided written informed consent.
Sample size calculations were based on change in 
lymphedema as indicated by volume and circumference (ie, 
extent of swelling). Whereas a 5% change over time is con-
sidered clinically significant,21 no evidence exists regarding 
the threshold for a clinically significant acute change in vol-
ume or circumference. Therefore, we aimed to detect a 
medium standardized effect (d = 0.3). With an α level of .05 
and a final sample of 17 patients, we achieved 80% statisti-
cal power to detect such an effect.
Experimental Design
This study involved a crossover design in which partici-
pants completed a high load and low load upper body resis-
tance exercise session separated by a 10- to 12-day 
wash-out period (Figure 1). Following comprehensive 
familiarization, participants completed the exercise ses-
sions in a randomized order. Participants were randomized 
in an allocation ratio of 1:1 using a random assignment 
computer program. A research methods consultant with no 
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patient contact was responsible for the randomization, and 
the exercise physiologists involved in supervising and 
assessing participants were blinded to the allocation 
sequence. The extent of swelling was assessed using bio-
impedance spectroscopy (BIS), dual-energy x-ray absorpti-
ometry (DXA; limb volume), and arm circumference 
measurements. The severity symptoms were assessed using 
the visual analogue scale (VAS; pain, heaviness, and tight-
ness) and a modified Brief Pain Inventory (BPI). 
Measurements were taken on both the affected and non-
affected arms pre-exercise, immediately post-exercise, 24 
hours post-exercise, and 72 hours post-exercise. Participants 
were instructed to maintain their usual lymphedema self-
care management regimen, physical activity levels, and diet 
throughout the intervention period.
Exercise Intervention
Prior to completing experimental sessions, all participants 
completed a series of 4 familiarization sessions over a 
2-week period. The familiarization sessions involved 1 to 2 
sets of 6 to 20 repetitions of 5 upper body resistance exer-
cises. The resistance exercises—chest press, lateral pull-
down, biceps curl, triceps extension, and lateral 
raise—focused on the major muscle groups in the upper 
body. Symptom response was monitored using VAS for 
pain, heaviness, and tightness before and after each ses-
sion.35 Load was prescribed and progressed individually. 
Both the high load and low load experimental exercise ses-
sions involved moderate- to high-intensity resistance exer-
cise. Participants were required to complete 2 sets of the 5 
upper body resistance exercises. The high load session 
involved lifting as much weight as possible for 6 to 8 rep-
etitions (ie, 6-8 repetition maximum [RM]), whereas the 
low load session involved lifting as much weight as possi-
ble for 15 to 20 repetitions (ie, 15-20 RM) of each exer-
cise.31 Similar to previous research, participants choose 
whether or not they wore a compression garment during the 
exercise sessions,22 and this choice was held consistent 
across both high and low load conditions. All sessions were 
performed in an exercise clinic in individual sessions super-
vised by an exercise physiologist.
Assessed for Eligibility (n= 60)
Excluded (n = 43)
• Declined to participate (n = 24)
• Not meeting criteria for clinical 
diagnosis of lymphoedema (n = 7)
• Physician decline (n = 1)
• Other reasons (n = 11)
Enrolled (n = 17)
High Load Resistance
Exercise Session;
Pre & Post Assessments
(n = 17)
Low Load Resistance
Exercise Session;
Pre & Post Assessments
(n = 17)
24 hours Post High Load
Assessment (n = 17)
24 hours Post Low Load
Assessment (n = 17)
72 hours Post High Load
Assessment (n = 17)
72 hours Post Low Load
Assessment (n = 17)
Resistance Exercise Familiarisation Sessions (n = 17)
Conditions performed in a
randomised order
separated by a 10-12 day
wash-out period
Figure 1. Flow of participants throughout trial.
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Outcome Measures
The extent of swelling and the severity of symptoms were 
assessed pre-exercise, immediately post-exercise, 24 hours 
post-exercise, and 72 hours post-exercise for both the high 
load and low load conditions. The length of time that par-
ticipants wore their compression garment prior to each 
assessment was recorded for all participants and held con-
sistent for each individual across all the time points exam-
ined. Participants were asked to report any deviations from 
their standard lymphedema self-care management regi-
men, physical activity levels, and diet at all assessment 
time points.
Extent of swelling. The severity of swelling associated 
with BCRL was assessed using standard objective mea-
sures: (a) BIS, (b) DXA, and (c) arm circumference mea-
surements. These 3 methods were used as there is no gold 
standard for the assessment of lymphedema and the method 
used to quantify the extent of swelling may influence the 
results.33,36-38 Impedance of the extracellular fluid in the 
affected and non-affected arms was assessed and compared 
using a range of frequencies according to guidelines of the 
BIS device manufacturer (ImpediMed IMPTM DF50; 
ImpediMed, San Diego, CA).32 The impedance values of 
the affected and unaffected arms were compared and the 
ratio reported (L-Dex score). DXA (Hologic Discovery A, 
Waltham, MA) was used to assess tissue composition of the 
limbs using a 3-compartment model sensitive to changes in 
fluid retention.39,40 Measurements were converted into vol-
ume using known densities of adipose tissue (0.9167 g/mL 
≈ 0.92 g/cm3), lean tissue (1.0615 g/mL ≈ 1.06 g/cm3), and 
bone (3.15 g/cm3), a method shown to correlate very highly 
(r = .996, P < .0001) with total arm volume measurement by 
plethysmography.41 Absolute values of the total volume for 
the affected arm as well as the volume difference between 
the affected and non-affected arms were reported. A con-
stant tension tape was used to assess regional circumfer-
ences of the affected and non-affected arms. Measurements 
were started just distal to the metacarpal-phalangeal joints 
and were taken at 4-cm intervals up the arm until the base of 
the axilla.42 Participants were seated with their arm posi-
tioned at 90° abduction resting on a massage table while 
arm circumference was assessed.33 Absolute values of the 
sum of all circumference measurements for the affected arm 
as well as the difference in the sum of all circumference 
measurements between the affected and the non-affected 
arms were reported. Circumference measurements at the 
point of greatest difference between the limbs was also 
assessed but not reported as the trends were consistent with 
the sum of circumference measurements.
Symptom severity. The severity of BCRL symptoms was 
assessed using: (a) VAS for pain, heaviness, and tightness 
and (b) the BPI questionnaire. VAS were used to quantify 
the severity of perceived pain, heaviness, and tightness in 
both the affected and non-affected arms.35 Participants rated 
their symptom severity from no pain/no discomfort (VAS 
score = 0) to very severe pain/worst imaginable discomfort 
(VAS score = 10). The BPI assessed any feelings of pain, 
the area of pain, the sensation (ie, discomfort, heaviness, 
aching, throbbing, etc.), and the extent to which the symp-
toms interfered with aspects of daily life over the previous 
24 hours.43 The BPI was modified so that each item was 
assessed with respect to the affected and non-affected limbs 
separately.21,42
Tolerance of the exercise sessions. Session rating of per-
ceived exertion was recorded immediately after the comple-
tion of each exercise session. Participants were asked to rate 
the overall difficulty of the session (ie, how hard/how much 
exertion was involved) on a scale of 6 (no exertion at all) to 
20 (maximal exertion). A 7-point Likert-type scale was also 
administered after the completion of each exercise session 
to assess the perception of tolerance of the exercise session 
(1 = intolerable, 7 = very tolerable).
Statistical Analyses
Data were analyzed using SPSS Statistics for Windows, 
Version 19.0 (IBM SPSS, Chicago, IL). Analyses included 
standard descriptive statistics, paired sample t tests, and 
repeated measures analysis of variance. All tests were 
2-tailed with statistical significance set at an α level of .05. 
Results are presented as mean ± standard deviation or num-
ber of participants (percentage of participants) for fre-
quency data.
Results
Participants
All participants enrolled completed the study. Participants 
had been diagnosed with lymphedema an average of 5.4 
years prior to involvement in this study (Table 1). 
Approximately 47% of the participants were diagnosed 
within the previous 3 years. All participants had surgical 
treatment (100%), with an average of 13 lymph nodes 
removed during the procedure. The majority of participants 
had received radiotherapy previously (88%), 65% had pre-
vious chemotherapy, and 47% previous/current hormone 
therapy. Participants were generally overweight or obese 
(percentage fat = 39.2 ± 5.6; body mass index = 31.5 ± 5.6 
kg/m2). According to common toxicity criteria grading,34 
30%, 35%, and 35% of participants had mild, moderate, 
and severe lymphedema, respectively. Approximately 18% 
of participants (3 of 17) chose to wear their compression 
garment during the resistance exercise sessions. No devia-
tions in standard lymphedema self-care management, 
physical activity, and diet behaviors were reported through-
out the study.
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Extent of Swelling
No significant differences were observed in volume or cir-
cumference of the affected arm across most of the time 
points examined (ie, pre-exercise, immediately post-exercise, 
24 hours post-exercise, and 72 hours post-exercise; Table 2). 
Arm circumference at 72 hours post-high load exercise was 
significantly lower that pre-exercise. When comparing the 
affected and non-affected arms, no significant differences 
were observed in the BIS ratio, arm volume difference, and 
arm circumference difference across any of the time points 
examined (Table 2). No significant changes were observed 
from pre-exercise to immediately post-exercise, 24 hours 
post-exercise, and 72 hours post-exercise in the BIS ratio, 
arm volume, or arm circumference (Figure 2A-C). No sig-
nificant differences were observed between the high load 
and low load exercise conditions across all of the time 
points examined (Table 2 and Figure 2A-C). There were no 
clear trends in terms of the impact of the resistance exercise 
on the extent of swelling, with individual responses varying 
from no change to decreased and/or increased swelling 
(Figure 3).
Symptom Severity
Visual analogue scale and BPI results were reported for the 
affected arm only, as the difference in symptom severity 
between the affected and non-affected arms did not change 
throughout all time points assessed (ie, affected arm scores 
were consistently significantly higher than the non-affected 
arm scores across all time points for both exercise condi-
tions). No significant differences in the severity of pain, 
heaviness, or tightness were observed across all time points 
examined (Table 2). Furthermore, no significant differences 
in extent to which the symptoms interfered with aspects of 
daily life were reported across most time points examined 
(Table 2). The interference score of the BPI was significantly 
lower than pre-exercise at 24 hours post-exercise, and 72 
hours post–low load exercise (Table 2). No significant 
changes were observed from pre-exercise to immediately 
post-exercise, 24 hours post-exercise, and 72 hours post-exercise 
in the severity of pain, heaviness, or tightness (Figures 2D-F). 
No significant differences were observed between the high 
load and low load exercise conditions across all of the time 
points examined (Table 2, Figure 2D-F). No clear trends 
existed in the symptom response to the exercise conditions as 
individual responses varied from no change to decreased and/
or increased severity of pain, heaviness, and tightness follow-
ing the exercise sessions (Figure 4).
Tolerance of the Exercise Sessions
Compliance was high with all participants completing all 
required exercise and assessment sessions (100% compli-
ance). No adverse events were recorded. The moderate- to 
high-intensity resistance exercise resulted in a rating of 
perceived exertion of approximately 12.5 ± 1.3, which is 
equivalent to a rating of “somewhat hard” (high load =12.6 
± 1.3; low load =12.3 ± 1.2). The exercise sessions were 
well tolerated with an average tolerance score of 6.7 ± 0.6 
out of a possible 7 (high load = 6.8 ± 0.4; low load =6.7 ± 
0.6). No differences in the rating of perceived exertion or 
tolerance existed between the high and low load resistance 
exercise sessions. The weight lifted differed significantly 
between the high load and low load conditions (high load 
=33.3 ± 4.7 kg; low load =21.5 ± 3.1 kg; P = .000).
Discussion
The primary findings of this small, exploratory study 
includes the following: (a) upper body resistance exercise 
performed in a controlled setting (ie, correct instruction and 
highly supervised) did not acutely increase the extent of 
swelling or the severity of symptoms in women with 
BCRL; (b) there was no difference in the acute response to 
upper body resistance exercise involving either high loads 
(6-8 RM) or low loads (15-20 RM); and (c) the moderate- to 
Table 1. Baseline Characteristics of Participants.a
Mean ± SD or n (%)
Age (years) 61.2 ± 9.1
Weight (kg) 81.0 ± 17.3
Body mass index (kg/m2) 31.5 ± 6.9
Percentage fat 39.2 ± 5.6
No. of comorbiditiesb 0.8 ± 0.7
No. of medications 2.4 ± 1.6
Time since cancer diagnosis (y) 8.1 ± 9.5
Cancer stage
 I 8 (47)
 II 5 (29)
 III 4 (24)
Surgery 17 (100)
 No. of lymph nodes removed 13 ± 8
Radiotherapy 15 (88)
Chemotherapy 11 (65)
Hormone therapy 8 (47)
Time since lymphedema 
diagnosis (years)
5.4 ± 5.6
Lymphedema severity
 BIS (L-Dex score) 23.7 ± 21.9
 Arm volume difference (%) 19.1 ± 13.9
 Arm circumference 
difference (%)c
18.7 ± 11.9
aResults are presented as mean ± standard deviation (SD) or number of 
participants (percentage of participants).
bComorbidity classified as cardiovascular disease, hypertension, diabetes, 
osteoporosis, and dyslipidemia.
cAt the point of greatest difference between limbs.
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Table 2. Extent of Swelling and Severity of Symptoms Throughout All Conditions.a
Pre-exercise Post-exercise 24 Hours Post-exercise 72 hours Post-exercise 
BIS (L-Dex score)
 High load 22.9 ± 22.2 22.6 ± 20.9 23.1 ± 20.8 23.2 ± 21.7
 Low load 24.5 ± 21.8 24.4 ± 22.9 24.4 ± 20.9 23.0 ± 21.0
Affected arm volume (mL)
 High load 4283.8 ± 1163.3 4306.3 ± 1150.0 4264.0 ± 1123.9 4312.9 ± 1161.2
 Low load 4253.6 ± 1103.6 4269.1 ± 1105.3 4267.2 ± 1095.4 4247.2 ± 1098.4
Volume difference between affected and non-affected arms (mL)
 High load 601.4 ± 571.5 645.2 ± 593.9 576.8 ± 577.8 667.2 ± 595.4
 Low load 604.8 ± 559.4 628.8 ± 551.5 541.2 ± 573.8 635.7 ± 577.1
Affected arm circumference (cm)
 High load 195.0 ± 34.5 194.7 ± 33.8 194.3 ± 34.0 193.9 ± 33.4b
 Low load 192.6 ± 28.7 192.2 ± 28.5 192.3 ± 28.4 191.7 ± 28.4
Circumference difference between affected and non-affected arms (cm)
 High load 15.2 ± 11.6 15.1 ± 11.2 14.9 ± 11.5 12.8 ± 10.5
 Low load 15.2 ± 10.8 14.9 ± 11.0 15.2 ± 11.1 14.7 ± 11.4
VAS—Pain (score)
 High load 0.7 ± 1.3 1.0 ± 1.4 0.6 ± 0.9 0.7 ± 1.5
 Low load 1.0 ± 2.2 1.4 ± 2.0 0.7 ± 1.3 0.5 ± 0.9
VAS—Heaviness (score)
 High load 1.3 ± 1.8 1.2 ± 1.5 1.0 ± 1.5 1.2 ± 1.9
 Low load 1.3 ± 2.4 1.8 ± 2.0 1.3 ± 1.8 1.0 ± 1.5
VAS—Tightness (score)
 High load 1.3 ± 1.5 1.6 ± 2.1 1.1 ± 1.2 1.1 ± 1.5
 Low load 1.3 ± 2.0 1.7 ± 1.9 1.3 ± 1.9 1.1 ± 1.4
BPI—Pain (score)
 High load 1.6 ± 2.0 1.8 ± 1.6 1.4 ± 1.4 1.6 ± 2.0
 Low load 1.9 ± 2.0 2.2 ± 1.5 1.3 ± 1.4c 1.4 ± 1.7c
BPI—Interference (score)
 High load 1.6 ± 1.6 — 1.2 ± 1.3 1.2 ± 1.5
 Low load 1.7 ± 1.6 — 1.0 ± 1.2b 1.1 ± 1.5b
aVisual analogue scale (VAS) and Brief Pain Inventory (BPI) scores are from the affected arm. No post-exercise measure for BPI—Interference  
(it assesses interference with activities of daily living in the past 24 hours).
bSignificantly different from pre-exercise.
cSignificantly different from post-exercise.
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Figure 2. Change in the extent of swelling (A-C) and severity of symptoms (D-F) from pre-exercise to immediately post-exercise, 24 
hours post-exercise, and 72 hours post-exercise for both high and low load conditions.
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Figure 3. Individual response in the extent of swelling from pre-exercise to immediately post-exercise, 24 hours post-exercise and 72 
hours post-exercise for both high (A-C) and low (D-F) load conditions.
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Figure 4. Individual response in the severity of symptoms from pre-exercise to immediately post-exercise, 24 hours post-exercise, and 
72 hours post-exercise for both high (A-C) and low (D-F) load conditions.
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high-intensity upper body resistance exercise sessions 
involving high (6-8 RM) and low (15-20 RM) loads were 
well tolerated by women with BCRL.
Despite the common advice for women with BCRL to 
avoid lifting with their affected limb to prevent an exacer-
bation, the upper body resistance exercise performed in a 
controlled setting during this study did not acutely increase 
the extent of swelling or the severity of lymphedema symp-
toms. This is the first investigation to examine the impact 
of moderate- to high-intensity upper body resistance exer-
cise on the affected limb of women with BCRL immedi-
ately after and in the days following an exercise session. 
The methodologies involved with the assessment of swell-
ing were among the most comprehensive used to date,33 
with changes in extracellular fluid, arm volume, and arm 
circumference measured both in absolute terms as well as 
the difference between affected and non-affected arms. The 
lack of significant change in any of these measures, cou-
pled with the observation that pain, heaviness, tightness, 
and the degree to which BCRL symptoms interfered with 
aspects of daily life did not worsen following the exercise 
suggests that appropriately prescribed and supervised 
resistance exercise is safe for women with BCRL. These 
findings support previous research examining the acute 
impact of low intensity resistance exercises targeting arm 
muscles in patients with mild to moderate BCRL.44 
Furthermore, the current findings add to an emerging body 
of evidence indicating that regular upper body resistance 
exercise is safe and does not cause exacerbations in women 
with BCRL.19-23
The current results provide initial evidence indicating 
that the load (high 6-8 RM or low 15-20 RM) used during 
upper body resistance exercise performed in a controlled 
setting did not affect the acute response in swelling or 
symptom severity in this sample of women with BCRL. It is 
well established that both high (generally ≥80% of 1 RM) 
and low (generally ≤60% 1 RM) load resistance exercise 
are effective at eliciting physiological adaptations that 
translate into improved muscle size, strength, and physical 
function (provided the intensity of the resistance exercise is 
moderate-high).28,30,31,45,46 However, a strong dose-response 
relationship exists between the load of resistance training 
and the magnitude of muscle size and strength gains.30,31,46,47 
For example, a meta-analysis of 140 trials indicates maxi-
mal gains in strength are observed with high load resistance 
exercise (80% of 1 RM effect size = 1.80 ± 1.30) compared 
with lower loads (eg, 70% of 1 RM effect size = 0.70 ± 
0.65).46 Importantly, a strong dose-response relationship 
exists between strength gains and improvements in physical 
function following resistance training,30 and high load resis-
tance exercise has also been reported to result in signifi-
cantly greater improvements in health-related quality of life 
when compared with low load resistance exercise.48 Despite 
the evidence for superior efficacy of high load resistance 
exercise, clinical experience indicates that women with 
BCRL are very apprehensive about using heavier weights, 
and allied health professionals who advise patients to exer-
cise typically stipulate low intensity exercise using very 
light loads.44 Results from the current study indicate that 
there was no difference in the acute response in swelling or 
symptom severity between high and low loads. Although 
continued study is required to determine the long-term 
effect, this initial evidence indicates that an appropriately 
designed and supervised upper body resistance exercise 
program involving the prescription of high loads was safe 
for women with BCRL and may lead to superior long-term 
improvements in physical structure and function.
Moderate- to high-intensity upper body resistance exer-
cise was well tolerated by women with BCRL. Additionally, 
there was no difference in the perceived difficulty or toler-
ability of the resistance exercise sessions involving either 
the low or high loads. This is an important outcome to high-
light, given the apprehension commonly experience by 
women with BCRL to participate in an exercise program 
involving upper body resistance exercise and the distribu-
tion of patients with mild, moderate, and severe lymph-
edema within this study. There is theoretical rationale12 and 
evidence19-23 that resistance exercise is an effective adjunct 
therapy for the management of BCRL. Our current study 
extends these findings indicating that both low and high 
loads are well tolerated by this patient population when 
appropriately prescribed and supervised.
There are limitations associated with this investigation 
worthy of comment. Although the sample size provided 
adequate power to detect a medium standardized effect (d = 
0.3), the relatively small number of participants limited the 
ability to detect changes of a small standardized effect (d = 
0.1-0.29). It is unclear what magnitude of effect is clinically 
significant when examining acute changes in lymphedema 
severity, so the results should be interpreted with caution. 
Due to the fact that assessments were taken up to 72 hours 
after the exercise sessions, the results at both 24 hours post-
exercise and 72 hours post-exercise may have been con-
founded by the other activities participants were involved in 
after the exercise bout (eg, mopping, gardening, etc.). 
However, participants were instructed to maintain normal 
daily activities throughout the duration of the study. 
Although every effort was made to ensure consistency in 
the length of time, participants wore their compression gar-
ment prior to each assessment point; self-report may have 
differed from actual behavior. The relatively small sample 
size prevents any subgroup analysis required to examine if 
the response to the exercise bouts differed according to 
lymphedema severity. However, this was the first explor-
atory study examining different exercise loads, and we 
employed a comprehensive battery of measures to assess 
lymphedema swelling and symptom severity including BIS, 
DXA, arm circumference, VAS (pain, heaviness, and 
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tightness), and the BPI questionnaire. Finally, our subjects 
were well-functioning individuals who were mostly moti-
vated to undertake the exercise study, and they may not be 
representative of all women with BCRL.
Conclusions
This exploratory, acute study suggests that when appropri-
ately prescribed and supervised, women with BCRL can 
perform moderate- to high-intensity upper body resistance 
exercise with both low and high loads without fear of exac-
erbating their lymphedema. Furthermore, this type of exer-
cise was well tolerated by a sample of women with BCRL, 
and we report no adverse events. These initial findings have 
important clinical significance, given the clear potential for 
resistance exercise to aid in the long-term management of 
BCRL through enhanced muscular strength and endurance 
as well as improved functional ability. Prospective trials 
examining the chronic response of upper body resistance 
exercise using low and high loads are warranted.
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